Drugs / Low Molecular Weight Sulfated Dextran
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00789308 | Jul 2008 → Jul 2013 | type 1 diabetes mellitus | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 2 | NCT00790439 | Jul 2008 → Oct 2009 | type 1 diabetes mellitus | National Institute of Allergy and Infectious Diseases (NIAID) | Withdrawn | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Low Molecular Weight Sulfated Dextran | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00789308 ↗ |
| Known as | LMW-SD | “Low Molecular Weight Sulfated Dextran (LMW-SD)” NCT00789308 ↗ |
| Action | Inhibit | “LMW-SD inhibits IBMIR by preventing the cascade that triggers it” NCT00789308 ↗ |
| Route | Other | “peritransplant intraportal and systemic treatment with either LMW-DS or heparin” PMID 30211831 ↗ Mar 2019 |